A case of hyperviscosity syndrome associated with Waldenström macroglobulinemia treated with membrane plasma exchange without predilution.

IF 1 Q4 UROLOGY & NEPHROLOGY CEN Case Reports Pub Date : 2024-07-04 DOI:10.1007/s13730-024-00912-z
Koichi Saiki, Tadashi Sofue, Chikako Higashiyama, Takafumi Shiga, Yuhei Aoki, Aiko Shiraishi, Yasushi Kunisho, Keisuke Onishi, Eisuke Nakamura, Tomoya Ishida, Tetsuo Minamino
{"title":"A case of hyperviscosity syndrome associated with Waldenström macroglobulinemia treated with membrane plasma exchange without predilution.","authors":"Koichi Saiki, Tadashi Sofue, Chikako Higashiyama, Takafumi Shiga, Yuhei Aoki, Aiko Shiraishi, Yasushi Kunisho, Keisuke Onishi, Eisuke Nakamura, Tomoya Ishida, Tetsuo Minamino","doi":"10.1007/s13730-024-00912-z","DOIUrl":null,"url":null,"abstract":"<p><p>A 75-year-old man with blurred vision and nasal bleeding was diagnosed with hyperviscosity syndrome and central retinal vein occlusion secondary to Waldenström macroglobulinemia. Serum total protein and IgM levels were undetectable. Because of the severe symptoms, we determined that immediate plasma-exchange treatment was required to decrease the blood viscosity. The initial plasma exchange was performed using the membrane isolation method with a predilution standby. A saline predilution replacement was prepared to decrease the total membrane pressure (TMP); however, the predilution protocol was not used because the planned treatment volume could be achieved without increasing the TMP. After two consecutive days of membrane plasma exchange, all serum biochemical tests were measurable, and IgM was below 4000 mg/dL. After chemotherapy, his visual symptoms improved, and he was discharged. Since it is difficult to assess the risk of elevated TMP prior to initial plasma exchange, membrane plasma exchange with a predilution standby may be a useful strategy for initial plasma exchange for hyperviscosity syndrome in terms of safety and efficiency.</p>","PeriodicalId":9697,"journal":{"name":"CEN Case Reports","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CEN Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13730-024-00912-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

A 75-year-old man with blurred vision and nasal bleeding was diagnosed with hyperviscosity syndrome and central retinal vein occlusion secondary to Waldenström macroglobulinemia. Serum total protein and IgM levels were undetectable. Because of the severe symptoms, we determined that immediate plasma-exchange treatment was required to decrease the blood viscosity. The initial plasma exchange was performed using the membrane isolation method with a predilution standby. A saline predilution replacement was prepared to decrease the total membrane pressure (TMP); however, the predilution protocol was not used because the planned treatment volume could be achieved without increasing the TMP. After two consecutive days of membrane plasma exchange, all serum biochemical tests were measurable, and IgM was below 4000 mg/dL. After chemotherapy, his visual symptoms improved, and he was discharged. Since it is difficult to assess the risk of elevated TMP prior to initial plasma exchange, membrane plasma exchange with a predilution standby may be a useful strategy for initial plasma exchange for hyperviscosity syndrome in terms of safety and efficiency.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一例与瓦尔登斯特伦巨球蛋白血症有关的高粘滞性综合征患者,在未进行预稀释的情况下接受了膜等离子交换治疗。
一名 75 岁的男子视力模糊并伴有鼻出血,被诊断为继发于瓦尔登斯特伦巨球蛋白血症的高粘滞性综合征和视网膜中央静脉闭塞。血清总蛋白和 IgM 水平检测不到。由于症状严重,我们决定立即进行血浆置换治疗,以降低血液粘稠度。最初的血浆置换采用膜分离法,预稀释备用。为了降低总膜压(TMP),我们准备了生理盐水预稀释替代物;但是,由于不增加 TMP 也能达到计划的治疗量,所以没有使用预稀释方案。经过连续两天的膜浆置换后,所有血清生化检测结果均可测量,IgM 低于 4000 mg/dL。化疗后,他的视觉症状有所改善,并已出院。由于在初始血浆置换前很难评估 TMP 升高的风险,因此,就安全性和效率而言,带预稀释备用的膜等离子体置换可能是高粘度综合征初始血浆置换的有效策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CEN Case Reports
CEN Case Reports UROLOGY & NEPHROLOGY-
CiteScore
1.90
自引率
0.00%
发文量
80
期刊介绍: Clinical and Experimental Nephrology (CEN) Case Reports is a peer-reviewed online-only journal, officially published biannually by the Japanese Society of Nephrology (JSN).  The journal publishes original case reports in nephrology and related areas.  The purpose of CEN Case Reports is to provide clinicians and researchers with a forum in which to disseminate their personal experience to a wide readership and to review interesting cases encountered by colleagues all over the world, from whom contributions are welcomed.
期刊最新文献
A case of PLA2R-positive membranous nephropathy with subsequent development of IgG4-related disease. Managing malignant hypertension with renal TMA: a case for caution in blood-pressure reduction. Acute tubulointerstitial nephritis associated with infliximab therapy in a patient with Crohn's disease: a case report. Acute tubulointerstitial nephritis following coronavirus disease 2019 mRNA vaccination: a pediatric case report. Tubulointerstitial nephritis with IgM-positive plasma cells complicated by liver failure.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1